EUVIMEDEUVIMED entdecken
Leitlinie

Inoperable POLE-mutated endometrial carcinoma: treatment beyond current guidelines

Bas L R Mandos, Sander Kelderman, Janneke E W Walraven, Heidi Rütten, Marieke Ploegmakers, Michiel Simons, Johanna M A Pijnenborg

International Journal of Gynecological Cancer · 2025-11 · 35 (11) · 102007

DOI: 10.1016/j.ijgc.2025.102007 ↗

Kurz gefasst

Leitlinie in der Zeitschrift International Journal of Gynecological Cancer, 2025-11. Verfasst von Bas L R Mandos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Radboud University Medical Center, Department of Obstetrics and Gynecology, Nijmegen, The Netherlands. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

DostarlimabEndometrial CarcinomaImmune Checkpoint InhibitorsNeoadjuvant TreatmentPOLE Mutation

Autor:innen und Institutionen

  • Radboud University Medical Center, Department of Obstetrics and Gynecology, Nijmegen, The Netherlands.
  • Radboud University Medical Center, Department of Medical Oncology, Nijmegen, The Netherlands.
  • Radboud University Medical Center, Department of Radiotherapy, Nijmegen, The Netherlands.
  • Radboud University Medical Center, Department of Radiology, Nijmegen, The Netherlands.
  • Radboud University Medical Center, Department of Pathology, Nijmegen, The Netherlands.
  • Radboud University Medical Center, Department of Obstetrics and Gynecology, Nijmegen, The Netherlands. Electronic address: Hanny.MA.Pijnenborg@radboudumc.nl.

Zitieren

APA

Mandos, B. L. R., Kelderman, S., Walraven, J. E. W., Rütten, H., Ploegmakers, M., Simons, M., & Pijnenborg, J. M. A. (2025). Inoperable POLE-mutated endometrial carcinoma: treatment beyond current guidelines. International Journal of Gynecological Cancer, 35(11), 102007. https://doi.org/10.1016/j.ijgc.2025.102007

Vancouver

Mandos BLR, Kelderman S, Walraven JEW, Rütten H, Ploegmakers M, Simons M, et al. Inoperable POLE-mutated endometrial carcinoma: treatment beyond current guidelines. International Journal of Gynecological Cancer. 2025;35(11):102007. doi:10.1016/j.ijgc.2025.102007

BibTeX
@article{Mandos2025,
  author = {Mandos, Bas L R and Kelderman, Sander and Walraven, Janneke E W and Rütten, Heidi and Ploegmakers, Marieke and Simons, Michiel and Pijnenborg, Johanna M A},
  title = {Inoperable POLE-mutated endometrial carcinoma: treatment beyond current guidelines},
  journal = {International Journal of Gynecological Cancer},
  year = {2025},
  volume = {35},
  number = {11},
  pages = {102007},
  doi = {10.1016/j.ijgc.2025.102007}
}
Kostenlos starten →